Ropivacaine Hydrochloride (Akorn, Inc.)


Welcome to the PulseAid listing for the Ropivacaine Hydrochloride drug offered from Akorn, Inc.. This Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Local Anesthesia [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: Akorn, Inc.
NON-PROPRIETARY NAME: Ropivacaine Hydrochloride
SUBSTANCE NAME: ROPIVACAINE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Local Anesthesia [PE]
ROUTE: EPIDURAL; INFILTRATION; PERINEURAL
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2016-04-11
END MARKETING DATE: 0000-00-00


Ropivacaine Hydrochloride HUMAN PRESCRIPTION DRUG Details:

Item DescriptionRopivacaine Hydrochloride from Akorn, Inc.
LABELER NAME: Akorn, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 5(mg/mL)
START MARKETING DATE: 2016-04-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 17478-081_00b70eb3-78ca-4f28-9d0e-6904eb4e421c
PRODUCT NDC: 17478-081
APPLICATION NUMBER: ANDA203955

Other ROPIVACAINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Akorn, Inc.Ropivacaine Hydrochloride
AuroMedics Pharma LLCRopivacaine Hydrochloride
Fresenius Kabi USA, LLCNaropin
General Injectables & Vaccines, IncNAROPIN
Hospira, Inc.Ropivacaine Hydrochloride
Sagent PharmaceuticalsRopivacaine Hydrochloride
Sandoz IncRopivacaine Hydrochloride